Primary |
Adrenal Insufficiency |
14.3% |
Cardiac Failure Congestive |
14.3% |
Hormone Replacement Therapy |
14.3% |
Hypertension |
14.3% |
Orthostatic Hypotension |
14.3% |
Pain |
14.3% |
Syncope Vasovagal |
14.3% |
|
Hypokalaemia |
33.3% |
Oedema Peripheral |
33.3% |
Condition Aggravated |
16.7% |
Hallucination |
16.7% |
|
Secondary |
Product Used For Unknown Indication |
24.7% |
Adrenogenital Syndrome |
13.7% |
Pain |
8.4% |
Drug Use For Unknown Indication |
4.7% |
Addison's Disease |
4.2% |
Adrenal Insufficiency |
4.2% |
Convulsion |
4.2% |
Analgesic Therapy |
3.7% |
Prophylaxis Against Renal Transplant Rejection |
3.7% |
Constipation |
3.2% |
Deep Vein Thrombosis |
3.2% |
Fatigue |
3.2% |
Multiple Myeloma |
3.2% |
Pulmonary Embolism |
3.2% |
Orthostatic Hypotension |
2.6% |
Chemotherapy |
2.1% |
Hyponatraemia |
2.1% |
Pain Prophylaxis |
2.1% |
Routine Health Maintenance |
2.1% |
Back Pain |
1.6% |
|
Drug Interaction |
25.0% |
Tremor |
9.1% |
Pulmonary Embolism |
6.8% |
Tumour Haemorrhage |
6.8% |
Death |
4.5% |
Platelet Count Decreased |
4.5% |
Renal Salt-wasting Syndrome |
4.5% |
Respiratory Distress |
4.5% |
Suicide Attempt |
4.5% |
Toxicity To Various Agents |
4.5% |
Weight Decreased |
4.5% |
Adrenocortical Insufficiency Acute |
2.3% |
Blood Creatinine Increased |
2.3% |
Cardiac Arrest |
2.3% |
Cardio-respiratory Arrest |
2.3% |
Epilepsy |
2.3% |
Hypercalcaemia |
2.3% |
Hypertensive Encephalopathy |
2.3% |
Ischaemic Stroke |
2.3% |
Klebsiella Bacteraemia |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
37.6% |
Drug Use For Unknown Indication |
30.3% |
Diabetes Mellitus |
3.0% |
Pain |
3.0% |
Hypertension |
2.4% |
Anxiety |
2.1% |
Adrenal Insufficiency |
1.9% |
Migraine |
1.9% |
Parkinson's Disease |
1.9% |
Prophylaxis |
1.8% |
Addison's Disease |
1.7% |
Depression |
1.6% |
Diffuse Large B-cell Lymphoma |
1.5% |
Adrenogenital Syndrome |
1.5% |
Nuclear Magnetic Resonance Imaging |
1.5% |
Osteoporosis |
1.4% |
Metastases To Bone |
1.3% |
Schizophrenia |
1.3% |
Atrial Fibrillation |
1.2% |
Rheumatoid Arthritis |
1.2% |
|
Weight Decreased |
14.1% |
Vomiting |
13.6% |
Pyrexia |
8.9% |
Somnolence |
6.8% |
White Blood Cell Count Decreased |
6.3% |
Rhabdomyolysis |
5.2% |
Syncope |
5.2% |
Death |
4.7% |
Renal Failure |
3.7% |
Dizziness |
3.1% |
Hypoaldosteronism |
3.1% |
Loss Of Consciousness |
3.1% |
Respiratory Failure |
3.1% |
Urinary Tract Infection |
3.1% |
Gastrointestinal Haemorrhage |
2.6% |
Pain |
2.6% |
Renal Failure Acute |
2.6% |
Septic Shock |
2.6% |
Thrombocytopenia |
2.6% |
Toxicity To Various Agents |
2.6% |
|
Interacting |
Adrenogenital Syndrome |
50.0% |
21-Hydroxylase Deficiency |
16.7% |
Convulsion |
16.7% |
Epilepsy |
16.7% |
|
Drug Interaction |
75.0% |
Renin Increased |
25.0% |
|